skip to content

Roche’s Third Quarter Sales 2024 Presentation

Roche has published its Third Quarter Sales for 2024 prior to the opening of the Swiss Stock Exchange on Wednesday, 23rd October 2024.

Agenda
OverviewThomas Schinecker, CEO Roche Group
Financial ResultsAlan Hippe, Chief Financial and IT Officer
Pharmaceuticals DivisionTeresa Graham, CEO Roche Pharmaceuticals
Diagnostics DivisionMatt Sause, CEO Roche Diagnostics
Q&ABruno Eschli, Head of Investor Relations

Webinar Replay

Investors

Past IR Events
View more Events